Anti-LKM antibodies are a series of autoantibodies directed against enzymes in the endoplasmic reticulum of hepatocytes and other cells that are mainly associated with various liver diseases. All of the following are TRUE about LKM antibodies, EXCEPT:

**Core Concept**
Autoantibodies against liver kidney microsomal (LKM) enzymes are a hallmark of autoimmune hepatitis type 2 (AIH-2). These antibodies target enzymes in the endoplasmic reticulum of hepatocytes and other cells, leading to liver damage and disease.

**Why the Correct Answer is Right**
LKM antibodies are primarily associated with autoimmune hepatitis type 2 (AIH-2), which is distinct from autoimmune hepatitis type 1 (AIH-1). The main target of LKM antibodies is the enzyme cytochrome P450 2D6 (CYP2D6). The presence of LKM antibodies in a patient with autoimmune hepatitis suggests a type 2 classification. Moreover, LKM antibodies are also associated with other conditions such as drug-induced liver injury and some cases of chronic hepatitis C.

**Why Each Wrong Option is Incorrect**
**Option A:** This statement is incorrect because LKM antibodies are indeed associated with various liver diseases, including autoimmune hepatitis type 2 (AIH-2).
**Option B:** This statement is incorrect because the target enzyme of LKM antibodies is indeed an enzyme in the endoplasmic reticulum of hepatocytes and other cells.
**Option C:** This statement is incorrect because LKM antibodies are primarily associated with autoimmune hepatitis type 2 (AIH-2), not type 1 (AIH-1).

**Clinical Pearl / High-Yield Fact**
Remember that the presence of LKM antibodies in a patient with autoimmune hepatitis suggests a type 2 classification, which is distinct from autoimmune hepatitis type 1 (AIH-1).

**Correct Answer: C.**

✓ Correct Answer: C. LKM-2: Infection with HDV